Dorsey & Whitney Trust’s Avidity Biosciences RNAM Stock Holding History

Dorsey & Whitney Trust’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,990	Closed	-$504K	–	742
2025 Q4	$504K	Hold	6,990	–	–	0.03%	434
2025 Q3	$305K	Buy	+6,990	New	+$283K	0.02%	534
2025 Q2	–	Sell	-6,990	Closed	-$206K	–	709
2025 Q1	$206K	Hold	6,990	–	–	0.01%	633
2024 Q4	$203K	Hold	6,990	–	–	0.01%	647
2024 Q3	$321K	Hold	6,990	–	–	0.02%	497
2024 Q2	$286K	Buy	+6,990	New	+$201K	0.02%	487

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Dorsey & Whitney Trust's RNAM Position: Q1 2026 in Review

Dorsey & Whitney Trust sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 6,990 shares — an estimated $504K sold.

Dorsey & Whitney Trust first reported a position in RNAM in Q2 2024 and held it in 6 quarters. The position peaked at $504K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Dorsey & Whitney Trust reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Dorsey & Whitney Trust sold 6,990 Avidity Biosciences shares in Q1 2026, an estimated $504K.
Dorsey & Whitney Trust first reported a position in Avidity Biosciences in Q2 2024 and held it in 6 quarters.
Dorsey & Whitney Trust's Avidity Biosciences position peaked at $504K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.